Process Technology Sample Clauses

Process Technology. 2.1.1 APT shall provide Siemens with the design information for each Process as more fully described in EXHIBIT 3 for the purpose of specifying the Process in accordance with Section 2.1.2. 2.1.2 APT and Siemens shall agree upon Process specifications to be described in Exhibit 3, which shall be finalized before Siemens begins production in accordance with Section 3. 2.1.3 Subject to the stipulations and procedure set forth in this Agreement and in accordance with the qualification plan described in Exhibit 5 Siemens shall bring up the Process which shall meet the specification in Exhibit 3 and deliver the required Wafers for qualification purposes.

Process Technology. (i) The Parties will jointly make available to Flash Forward the process technology developed under the JMDY Agreement, the Product Development Agreement or the Common R&D Agreement and applicable to the manufacturing and testing of NAND Flash Memory Products and R/W (“Process Technology”) on a mutually agreed schedule. (ii) Transfers of Process Technology and process integration for new processes developed pursuant to the JMDY Agreement and that appear on the JMDY Roadmap (as defined in the JMDY Agreement), including those processes developed at AMC or any other facility in accordance with the JMDY Agreement, will be jointly reviewed and discussed by the Parties and will be made in a mutually satisfactory manner. All process integration for new process originating from AMC will be led by Toshiba employees, to the extent reasonably possible. Toshiba and SanDisk will cause their respective employees to cooperate in achieving an efficient transition from development module to operating process and volume production. (iii) The transfer of Process Technology to JV Space shall be deemed complete when the transferred Process Technology passes a reasonable qualification procedure to be mutually agreed upon by the Parties. (iv) [***] (v) [***]

Process Technology. ABX shall own all ABX Process Technology; provided, however, that, on and after the designation of a Candidate Drug that binds to and is directed against a Collaboration Antigen, AZ shall own, and ABX and its Affiliates shall assign to AZ, the Manufacturing Data and any cell lines, including research and master cell banks, expressing Candidate Drugs, Licensed Products or other Antibodies that bind to and are directed against such Collaboration Antigen. Subject to the process development and manufacturing and supply commitments set forth in this Article 7 and in the Process Science/Clinical Manufacture Agreement and the Manufacturing and Supply Agreement, ABX and its Affiliates shall grant to AZ a [Confidential treatment requested] worldwide, right and license (with the right to grant sublicenses through multiple tiers of sublicensees subject to the last sentence of this Section 7.9) under the ABX Process Patent Rights and ABX Process Know-How Rights to Exploit Antibodies, Candidate Drugs and Licensed Products for which ABX is performing activities under the Process Science/Clinical Manufacture Agreement for use in the Commercial Field. From and after the date that ABX ceases to perform process development or manufacturing and supply activities with respect to an Antibody, a Candidate Drug or a Licensed Product under the Process Science/Clinical Manufacture Agreement and the Manufacturing and Supply Agreement, ABX and its Affiliates shall grant to AZ the exclusive, worldwide, [Confidential treatment requested] right and license (with the right to grant sublicenses through multiple tiers of sublicensees subject to the last sentence of this Section 7.9) under the ABX Process Patent Rights and ABX Process Know-How Rights to Exploit such Antibody, Candidate Drug and Licensed Product for use in the Commercial Field. Notwithstanding anything to the contrary in this Agreement, the right of AZ to grant sublicenses under the ABX Process Patent Rights and ABX Process Know-How Rights applicable to an Antibody, Candidate Drug or Licensed Product shall be limited solely to the extent Reasonably Necessary to manufacture and supply such Antibody, Candidate Drug or Licensed Product for use in the Commercial Field (and related process development and testing activities).

Process Technology. Subject to the license grants to AZ under this Agreement, as between the Parties, ABX shall own and retain all right, title and interest in and to all of the ABX Process Technology (together with all Patent Rights and other intellectual property rights therein). AZ shall own and retain all right, title and interest in and to all of the AZ Process Technology (together with all Patent Rights and other intellectual property rights therein).

Process Technology. In no event may Conexant or any Conexant Affiliate sublicense any Licensed Patent or Transferred Know-How to any third party for the purpose of enabling such third party to provide semiconductor fabrication services (or similar services) to anyone other than Conexant or Conexant Affiliates.

Process Technology. Spansion desires to have SMIC manufacture the Contract Wafers at the Facilities using certain Spansion Process Technology, provided the Facilities meet Spansion’s specifications. To this end, the Parties shall execute from time to time during the term individual Process Supplements substantially in the form set forth in Exhibit A1 for each Spansion Process (e.g., for a particular process node) to be implemented at the Facilities. The initial Process Supplement will be provided by Spansion within fifteen (15) days after execution of this Foundry Agreement and attached hereto as Exhibit A1.

Process Technology. 2.1.1. APT shall provide CSMC with the process / design information for each Process step as described in Exhibit 2 for the purpose of specifying the Process in accordance with Section 2.1.2. 2.1.2. Both parties agree that technology transfer and qualification will proceed first on APT’s Mosfet Mos8 products / technology with the intent that the Process is qualified within six to nine (6-9) months of the date this Agreement is executed. 2.1.3. CSMC agrees to assign a dedicated customer engineer to APT for the duration of this agreement. 2.1.4. APT and CSMC shall agree upon Process specifications to be documented in Exhibit 3, which shall be finalized before CSMC begins production in accordance with Section 3. [ * ] = CONFIDENTIAL TREATMENT REQUESTED APT / CSMC Foundry Agreement 2.1.5. Subject to the stipulations and procedures set forth in this Agreement and in accordance with the qualification plan CSMC shall install the Processes meeting the specifications in Exhibit 3 and deliver Wafers for qualification purposes.

Process Technology. 2.1.1 APT shall provide EPISIL with the design information for each Process as described in Exhibit 2 for the purpose of specifying the Process in accordance with Section 2.1.2. 2.1.2 Both parties agree that technology transfer and qualification will proceed first on APT’s [*] products / process with the intent that Processes are qualified for each technology listed in Exhibit 5 within [*] months of the date this Agreement is executed. APT and EPISIL shall agree upon Process specifications to be described in Exhibit 3, which shall be finalized before EPISIL begins production in accordance with Section 3. Subject to the stipulations and procedures set forth in this Agreement and in accordance with the qualification plan described in Exhibit 4, EPISIL shall install the Processes meeting the specifications in Exhibit 3 and deliver Wafers for qualification purposes.

Process Technology. Spansion desires to have SMIC manufacture the Contract Wafers at the Facilities using certain Spansion Process Technology, provided the Facilities meet Spansion’s specifications. To this end, the Parties shall execute from time to time during the term individual Process Supplements substantially in the form set forth in Exhibit A1 for each Spansion Process (e.g., for a particular process node) to be implemented at the Facilities. The initial Process Supplement will be provided by Spansion within fifteen (15) days after execution of this Foundry Agreement and attached hereto as Exhibit A1. (a) Process Specifications. With respect to each Process Supplement, Spansion shall deliver the specifications listed and described in the Process Supplement in accordance with the time schedule provided in such Process Supplement. Without limiting the foregoing, SMIC will contribute necessary technical resources and manpower for successfully establishing the Spansion Process at SMIC within the schedule set forth in such Process Supplement. SMIC agrees to use its best efforts to achieve the milestones or execute statements of work that may be identified in Process Supplements or as otherwise mutually agreed. If SMIC fails to meet the scheduled dates or milestones in a Process Supplement, SMIC shall provide Spansion with a recovery plan to meet future scheduled dates or milestones. (b) Phase-In Projects. SMIC agrees to implement each Spansion Process at the applicable Facilities in accordance with the program schedule set forth in the corresponding Process Supplement. Each Party shall promptly provide the other with notice as soon as possible after it has reason to believe it will be unable to timely deliver any required deliverable together with the reason for such delay and the date on which such Party reasonably expects to deliver any such required deliverable. The Parties agree that this Section shall not be construed to relieve a Party of its obligation to continue in the performance of its responsibilities notwithstanding any delay by the other Party.